BSTZ vs PLGO: Which Stock Is the Better Buy?
BlackRock Science and Technology Term Trust and Pelagos Insurance Capital Limit side by side — fundamentals from SEC filings, refreshed nightly. Sector: Financial Services.
AI verdict — BSTZ vs PLGO, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| BlackRock Science and Technology Term Trust (BSTZ) | Pelagos Insurance Capital Limit (PLGO) | |
|---|---|---|
| Market cap | $2.0B | $2.0B |
| Revenue (latest FY) | $316.13M | $2.17B |
| Net income (latest FY) | $314.36M | $225.50M |
| Revenue growth (5y CAGR) | — | 12.7% |
| Net margin | 99.4% | 10.4% |
| Return on equity | 18.3% | 9.4% |
| P/E ratio | 6.3 | 6.5 |
| Dividend yield | 6.7% | 2.6% |
| Profitable years (of last 10) | 3 | 4 |
| Positive free cash flow | — | No |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full BSTZ vs PLGO breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open BSTZ's full financials → Open PLGO's full financials →More comparisons
Frequently asked questions
Which is bigger, BSTZ or PLGO?
Pelagos Insurance Capital Limit is larger by market capitalization — $2.0B versus $2.0B.
Which grows faster, BSTZ or PLGO?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.